期刊文献+

脂联素及其受体2在肝细胞癌组织中的表达和临床意义 被引量:2

Expression of adiponectin and adiponectin receptor 2 in hepatocellular carcinoma tissue and its clinical significance
下载PDF
导出
摘要 目的 探讨脂联素及其受体2在人肝细胞癌组织和癌旁组织中的表达及其与临床病理特征之间的关系。方法 选取武汉大学人民医院2012年7月~2014年7月手术切除的48例肝细胞癌患者和48例健康体检对照者作为研究对象,运用放射免疫法检测肝细胞癌患者和健康对照者的血清脂联素水平,采用免疫组织化学法检测脂联素及其受体2在人肝细胞癌组织和癌旁组织的表达,并统计分析肝癌组织中脂联素及其受体2的表达高低与临床病理特征之间的关系。结果 肝细胞癌患者的外周血清中脂联素水平为(12.25±5.23)μg/m L,低于健康对照者的(27.36±8.26)μg/m L,差异有高度统计学意义(P〈0.01)。脂联素在肝癌组织和癌旁组织中的阳性率分别为41.67%和81.25%,脂联素受体2在肝癌组织和癌旁组织中的阳性率分别为31.25%和77.08%,差异有高度统计学意义(P〈0.01)。进一步的分析发现,脂联素和脂联素受体2的阳性率与肝细胞癌患者的年龄、性别、HBs Ag、抗-HCVAb、是否合并有肝硬化、肿瘤大小、组织学分级和肿瘤分期均没有明显相关性,差异无统计学意义(P〉0.05),但不同淋巴结转移情况和血管侵犯的肝癌组织中的脂联素和脂联素受体2的阳性率,差异有统计学意义(P〈0.05)。结论 脂联素及其受体2的表达下降可能与人肝细胞癌的发生发展密切相关。 Objective To investigate the expression of adiponectin and adiponectin receptor 2 (AdipoR2) in hepatocellular carcinoma (HCC) tissue and para-carcinoma tissue, and their correlation to clinicopathological features. Methods Forty-eight HCC patients undergoing partial hepatectomy and forty-eight healthy people in Renmin Hospital of Wuhan University from July 2012 to July 2014 were selected as research objects. Serum adiponectin level of HCC patients and normal controls was determined using RIA kit. The expression of adiponectin and AdipoR2 in cancerous and para- cancerous tissues were detected by immunohistochemical method. The correlations of clinical pathologic parameters with the adiponectin and AdipoR2 expression in cancerous tissue were analyzed respectively. Results HCC patients had a significantly lower concentration of serum adiponectin than nomal controls [(12.25±5.23) vs (27.36±8.26) μg/mL, P 〈 0.01]. The expression rate of adiponectin and AdipoR2 in cancerous tissues were lower than those in the para-cancerous tissues obviously (41.67% vs 81.25%, 31.25% vs 77.08%, P 〈 0.01). There were no statistical differences of the expression of adiponectin and AdipoR2 in age, sexuality, HBsAg, anti-HCV Ab, liver cirrhosis, tumor size, histological differentiation degrees and stages of TNM, but there were statistical difference of the expression of adiponectin and AdipoR2 with vascular invasion and lymphatic metastasis (P 〈 0.05). Conclusion The decrease of adiponectin and AdipoR2 expression may be closely relevant to the HCC progression.
出处 《中国医药导报》 CAS 2015年第33期34-37,共4页 China Medical Herald
基金 中国肝炎防治基金会天晴肝病研究基金(CFHPC20132133)
关键词 肝细胞癌 脂联素 脂联素受体 免疫组织化学 Hepacellular carcinoma Adiponectin Adiponectin receptor 2 Immunohistochemistry
  • 相关文献

参考文献22

  • 1Calle EE,Rodriguez C,Walker-Thurmond K, et al. Over- weight, obesity, andmortality from cancer in a prospectively studied cohort of U.S. adults [J]. N Engl J Med,2003,348 (17) : 1625-1638..
  • 2Gallagher E J, LeRoith D. Obesity and Diabetes:the increased risk of cancer and cancer-related mortality [J]. Physiol Rev, 2015,95(3) :727-748.
  • 3Starley BQ,Calcagno CJ,Harrison SA. Nonalcoholic fatty liver disease and hepatocellular eareinoma:a weighty con- nection [J]. Hepatology, 2010,51 (5) : 1820-1832.
  • 4戴锴,田德英.瘦素促进人肝癌细胞侵袭性生长的体外研究[J].肿瘤,2007,27(6):425-428. 被引量:4
  • 5Ramani K,Yang H,Xia M,et al. Leptin's mitogenic effect in human liver cancer cells requires induction of both methio- nine adenosyltransferase 2A and 2 beta Hepatology,2008, 47(2) :521-531.
  • 6Sugiyama M,Takahashi H,Hosono K,et al. Adiponeetin inhibits eolorectal cancer cell growth through the AMPK/ roTOR pathway [J]. Int J 0neol,2009, 34(2) : 339-344.
  • 7Guleelik MA, Colakoglu K,Dineer H,et al. Associations be- tween adiponeotin and two different cancers:breast and colon [J]. Asian Pac J Cancer Prev, 2012,13(1) : 395-398.
  • 8Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in nonalcoholic fatty liver disease:an emerging menace [J]. J Hepatol,2012,56(6) : 1384-1391.
  • 9Chitturi S, Wong VW, Farrell G, et al. Nonalcoholic fatty liv- er in Asia: firmly entrenched and rapidly gaining ground [J]. J Gastroemerol Hepatol,2011,26(Suppt 1) : 163-172.
  • 10Greenberg AS,Obin MS. Obesity and the role of adipose tis- sue in inflammation and metabolism [J]. Am J Clin Nutr, 2006,83(2) :461S - 465S.

二级参考文献13

  • 1TESTA R,FRANCESCHINI R,GIANNINI E,et al.Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis[J].J Hepatol,2000,33(1):33-37.
  • 2HONDA H,IKEJIMA K,HIROSE M,et al.Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver[J].Hepatology,2002,36(1):12-21.
  • 3CALLE EE,RODRIGUEZ C,WALKER-THURMOND K,et al.Overweight,obesity,and mortality from cancer in a prospectively studied cohort of U.S.adults[J].N Engl J Med,2003,348(17):1625-1638.
  • 4NAIR S,MASON A,EASON J,et al.Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis[J]?Hepatology,2002,36(1):150-155.
  • 5BLUM WF,ENGLARO P,ATTANASIO AM,et al.Human and clinical perspectives on leptin[J].Proc Nutr Soc,1998,57(3):477-485.
  • 6CLEARY MP,PHILLIPS FC,GETZIN SC,et al.Genetically obese MMTV-TGF-alpha/Lep(ob)Lep(ob)female mice do not develop mammary tumors[J].Breast Cancer Res Treat,2003,77(3):205-215.
  • 7FRANKENBERRY KA,SOMASUNDAR P,MCFADDEN D W,et al.Leptin induces cell migration and the expression of growth factors in human prostate cancer cells[J].Am J Surg,2004,188(5):560-565.
  • 8EDWARDS JG,MCLAREN J,JONES JL,et al.Matrix metalloproteinases 2 and 9(gelatinases A and B)expression in malignant mesothelioma and benign pleura[J].Br JCancer,2003,88(10):1553.1559.
  • 9LEEMAN MF,CURRAN S,MURRAY GI.New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression[J].J Pathol,2003,201(4):528-534.
  • 10HOJILLA CV,MOHAMMED FF,KHOKHA R.Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development[J].Br J Cancer,2003,89(10):1817-1821.

共引文献3

同被引文献26

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部